1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015

Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015" provides data on the Polycystic Kidney Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Polycystic Kidney Disease. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Polycystic Kidney Disease. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Polycystic Kidney Disease Global Clinical Trials Review, H1, 2015
Table of Contents
Introduction 6
Polycystic Kidney Disease 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Polycystic Kidney Disease 25
Subjects Recruited Over a Period of Time 27
Clinical Trials by Sponsor Type 28
Prominent Sponsors 29
Top Companies Participating in Polycystic Kidney Disease Therapeutics Clinical Trials 30
Prominent Drugs 31
Clinical Trial Profiles 32
Clinical Trial Overview of Top Companies 32
Otsuka Holdings Co., Ltd. 32
Clinical Trial Overview of Otsuka Holdings Co., Ltd. 32
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Kadmon Corporation, LLC 35
Clinical Trial Overview of Kadmon Corporation, LLC 35
Daiichi Sankyo Company, Limited 36
Clinical Trial Overview of Daiichi Sankyo Company, Limited 36
XORTX Pharma Corp. 37
Clinical Trial Overview of XORTX Pharma Corp. 37
Novartis AG 38
Clinical Trial Overview of Novartis AG 38
GLG Pharma LLC 39
Clinical Trial Overview of GLG Pharma LLC 39
Clinical Trial Overview of Top Institutes / Government 40
Radboud University 40
Clinical Trial Overview of Radboud University 40
Mayo Clinic 41
Clinical Trial Overview of Mayo Clinic 41
Shanghai Changzheng Hospital 42
Clinical Trial Overview of Shanghai Changzheng Hospital 42
Mario Negri Institute for Pharmacological Research 43
Clinical Trial Overview of Mario Negri Institute for Pharmacological Research 43
The National Institute of Diabetes and Digestive and Kidney Diseases 44
Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 44
Kyorin University 45
Clinical Trial Overview of Kyorin University 45
Toranomon Hospital 46
Clinical Trial Overview of Toranomon Hospital 46
Medical University of Vienna 47
Clinical Trial Overview of Medical University of Vienna 47
Assistance Publique - Hopitaux de Paris 48
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris 48
Tehran University of Medical Sciences 49
Clinical Trial Overview of Tehran University of Medical Sciences 49
Five Key Clinical Profiles 50
Appendix 82
Abbreviations 82
Definitions 82
Research Methodology 83
Secondary Research 83
About GlobalData 84
Contact Us 84
Disclaimer 84
Source 84

List of Tables

Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2015* 7
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 10
Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 11
Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2015* 12
Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 13
Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 14
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2015* 21
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 22
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Polycystic Kidney Disease Therapeutics, Global, Withdrawn Clinical Trials, 2015* 25
Polycystic Kidney Disease Therapeutics, Global, Terminated Clinical Trials, 2015* 26
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 28
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Holdings Co., Ltd., 2015* 32
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015* 34
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kadmon Corporation, LLC, 2015* 35
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 36
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by XORTX Pharma Corp., 2015* 37
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 38
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by GLG Pharma LLC, 2015* 39
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015* 40
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 41
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Shanghai Changzheng Hospital, 2015* 42
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Mario Negri Institute for Pharmacological Research, 2015* 43
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2015* 44
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyorin University, 2015* 45
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Toranomon Hospital, 2015* 46
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2015* 47
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2015* 48
Polycystic Kidney Disease Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015* 49

List of Figures

Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2015* 7
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 8
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 9
Polycystic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 10
Polycystic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 11
Polycystic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 12
Polycystic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 13
Polycystic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 14
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015* 15
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 16
Polycystic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 17
Proportion of Polycystic Kidney Disease to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015* 18
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 19
Polycystic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 20
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2015* 21
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 22
Polycystic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2015* 23
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2015* 24
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 27
Polycystic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 28
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 29
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 30
Polycystic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 31
GlobalData Methodology 83

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.